Financials

News Ideas Discussions Technicals Forecast Seasonals Options

INBX fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to Inhibrx Biosciences, Inc. operating, investing, and financing activities

INBX free cash flow for Q1 25 is -35.92 M USD. For 2024, INBX free cash flow was -197.01 M USD and operating cash flow was -194.41 M USD.

Q1 '23

Q2 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: USD

Q1 '23

Q2 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—